-
ACCESS TO HEALTHCARE, UTILIZATION, AND EXPENDITURES AMONG ADULTS WITH DIABETES AND CARDIORENAL COMORBIDITIES
Feb 25, 2026, 14:41 PM -
ANALYSIS OF GENE THERAPIES AUTHORIZED BY HEALTH CANADA, AND COMPARISON WITH THE U.S. FOOD AND DRUG ADMINISTRATION, AND THE EUROPEAN MEDICINES AGENCY
Feb 25, 2026, 14:41 PM -
USING THE DELPHI METHOD TO IDENTIFY EVIDENCE GAPS IN SUPPORT OF HTA SUBMISSIONS FOR RARE PEDIATRIC CONDITIONS: A CASE STUDY IN NON-DYSTROPHIC MYOTONIAS
Feb 25, 2026, 14:41 PM -
A COMPARATIVE ASSESSMENT OF TRAVEL BURDEN AND PRODUCTIVITY LOSS FOR CAR T-CELL THERAPY AND BISPECIFIC ANTIBODY TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY LBCL USING US CLAIMS DATA
Feb 25, 2026, 14:41 PM -
INTERNATIONAL REFERENCE PRICING CAPS ARE HIGHLY DESIGN-SENSITIVE: CAP-SETTING COUNTRIES AND ACCESS SIGNALS FOR INCRETIN THERAPIES
Feb 25, 2026, 14:41 PM -
POTENTIAL BENEFITS OF RSV VACCINATION IN COLOMBIAN ADULTS AGED 60 AND OVER: A COST-UTILITY ANALYSIS
Feb 25, 2026, 14:41 PM -
IMPACT OF TELEMEDICINE ENCOUNTERS ON SURVIVAL OUTCOMES: A TIME-VARYING COX ANALYSIS USING EHR-DERIVED DATA
Feb 25, 2026, 14:41 PM -
A MARKOV COHORT MODEL EVALUATING THE COST-EFFECTIVENESS OF ASCIMINIB VERSUS STANDARD TYROSINE KINASE INHIBITORS IN THIRD-LINE CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA: A FIVE-YEAR ANALYSIS FROM THE PAYER PERSPECTIVE
Feb 25, 2026, 14:41 PM -
PREVALENCE AND ASSOCIATION OF VITAMIN D DEFICIENCY WITH DIABETIC NEPHROPATHY IN TYPE 2 DIABETES, A HOSPITAL-BASED CROSS-SECTIONAL STUDY
Feb 25, 2026, 14:41 PM -
RISKY BUSINESS: HOW HEALTH PREFERENCE RESEARCH CAPTURES RISK TOLERANCE
Feb 25, 2026, 14:41 PM -
BRIDGING EVIDENCE AND ACCESS: SURVEY-BASED INSIGHTS INTO HOW BIOPHARMACEUTICAL MANUFACTURERS DEVELOP AND SHARE HCEI RESOURCES
Feb 25, 2026, 14:41 PM -
UNDERSTANDING PERSPECTIVES, BARRIERS AND ENABLERS FOR CLINICAL TRIAL PARTICIPATION IN REPRESENTATIVE PATIENT POPULATIONS
Feb 25, 2026, 14:41 PM -
SLEEP DISORDER DIAGNOSIS IN ADOLESCENCE AND SUBSEQUENT MENTAL HEALTH DIAGNOSES - A RETROSPECTIVE COHORT STUDY
Feb 25, 2026, 14:41 PM -
REAL-WORLD TREATMENT PATTERNS IN COMMERCIALLY INSURED PATIENTS WITH RECURRENT OR PROGRESSIVE ENDOMETRIAL CANCER (EC) IN THE USA
Feb 25, 2026, 14:41 PM -
THE VALUE VOCABULARY: AN ANALYSIS OF SOCIETAL TERMS IN CDA-AMC AND INESSS HEALTH TECHNOLOGY ASSESSMENT DECISION MAKING
Feb 25, 2026, 14:41 PM -
PATTERNS AND PREDICTORS OF LUNG CANCER CARE TRAJECTORIES: A SEQUENCE ANALYSIS OF INSURANCE CLAIMS
Feb 25, 2026, 14:41 PM -
INCORPORATING PUBLISHED SUBGROUP ANALYSES INTO MULTILEVEL NETWORK META-REGRESSION VIA BAYESIAN SYNTHETIC LIKELIHOOD
Feb 25, 2026, 14:41 PM -
SOCIODEMOGRAPHIC AND CLINICAL FACTORS ASSOCIATED WITH TIME TO TREATMENT INITIATION AND CARE PATHWAYS IN NON-METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) IN COLOMBIA: A REAL-WORLD EVIDENCE STUDY
Feb 25, 2026, 14:41 PM -
COMPARING THE DISEASE BURDEN OF MIGRAINE BETWEEN USERS OF CGRP MONOCLONAL ANTIBODIES AND PREVENTIVE GEPANTS
Feb 25, 2026, 14:41 PM -
GLOBAL AVAILABILITY AND ACCESS TO EVIDENCE-BASED ANTI-OBESITY PHARMACOTHERAPIES: A SYSTEMATIC ASSESSMENT OF REGULATORY AND REIMBURSEMENT LANDSCAPES
Feb 25, 2026, 14:41 PM
